Patents by Inventor Tong XUE

Tong XUE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250091971
    Abstract: The present disclosure provides an ?-olefin extractant and a method for separating an alkane and an ?-olefin, wherein the ?-olefin extractant comprises an alcohol-amine, a saturated monoketone having a carbon chain length of 7-10 and a monovalent salt of a Group IB metal, wherein the alcohol-amine, the saturated monoketone having a carbon chain length of 7-10 and the monovalent salt of a Group IB metal are in a mass ratio of (0.9-2.0):(0.8-1.5):(0.1-0.6). In the present disclosure, the technical principle of complexing extractive rectification is utilized and achieves the purpose of separating an olefin from an alkane by adding a complexing extractant to form a relatively stable complex between a metals and the olefin. The present disclosure has advantages of good separation effect and high product yield.
    Type: Application
    Filed: December 9, 2022
    Publication date: March 20, 2025
    Inventors: Tong Liu, Zhen Qian, Zhifei Li, Xiaolong Zhang, Yanpeng Xu, Gang Wang, Taishan Li, Hongyu Liu, Qiang Xue, Xu Wang
  • Patent number: 12234286
    Abstract: Provided are antibodies that specifically bind to TIGIT (T cell immunoreceptor with Ig and ITIM domains, WUCAM or Vstm3) and inhibit Tigit-mediated cellular signaling and activities in immune cells. The anti-TIGIT antibodies can be used to treat or diagnose cancer, infectious diseases or other pathological disorders that may be modulated by Tigit-mediated functions.
    Type: Grant
    Filed: November 24, 2021
    Date of Patent: February 25, 2025
    Assignee: BEIGENE SWITZERLAND GMBH
    Inventors: Tong Zhang, Liu Xue, Qi Liu, Min Wei, Kang Li
  • Publication number: 20230287333
    Abstract: The present invention belongs to the field of bioengineering technologies, and in particular, to a production method of recombinant Escherichia coli (E. coli) and high-purity ursodeoxycholic acid (UDCA). The present invention constructs novel double-enzyme co-expression gene engineered bacteria, that is, recombinant E. coli. The bacteria simultaneously expresses 7?-hydroxysteroid dehydrogenase (7?-HSDH) and glucose dehydrogenase (GDH). The bacteria is applicable to the production of high-purity UDCA. The yield of a target product is increased through the joint expression and application of 7?-HSDH and GDH. The production method of high-purity UDCA in the present invention is simple, generates a small amount of impurities in a production process, is a green process that satisfies environmental protection requirements, and has significant industrial application value.
    Type: Application
    Filed: December 11, 2022
    Publication date: September 14, 2023
    Applicant: XI'AN YUEDA BIOTECHNOLOGY CO., LTD.
    Inventors: Tian ZHANG, Tong XUE, Lihui ZHU